July 16, 2024
You are here:  Home  >  Latest news  >  Current Article

Stellar ushers in new common stock to take over Canadian firm; will also take over its name


Port Hueneme-based Stellar Biotechnologies acquired a privately held Canadian therapeutics firm Edesa as a subsidiary in a share exchange March 8 and said it may decide to wind down its legacy manufacturing operations. Stellar issued new common stock in exchange for Edesa shares, leaving Edesa shareholders with a 90 percent interest in Stellar and current…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.